{"task_id": "35759c0b0202c125", "source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 691/905)", "text": "RANK ligand, given SC twice yearly \ue001 reabsorption.\n\n--- Page 697 ---\n683\nClinical chemistry\nIt is better to scan the hip than the lumbar spine. Bone mineral density (g/cm\n2) \nis compared with that of a young healthy adult. The \u2018T-score\u2019 is the number of \nstandard deviations (SD, p751) the bone mineral density (BMD) is from the youthful \naverage. Each decrease of 1 SD in BMD \u2248 2.6-fold \ue000 in risk of hip fracture.\nTable 14.5 Interpreting DEXA bone scan results\nT-score >0\nBMD is better than the reference.\n0 to \u03a91\nBMD is in the top 84%: no evidence of osteoporosis.\n\u03a91 to \u03a92.5\nOsteopenia. Risk of later osteoporotic fracture. Off er lifestyle advice. \n\u03a92.5 or worse\nOsteoporosis. Off er lifestyle advice and treatment (p682). Repeat \nDEXA in 2yrs.\nSome indications for DEXA:\n  \u2022 NICE suggests DEXA if previous low-trauma fracture, or for women \u2265 65yrs with one \nor more risk factors for osteoporosis, or younger if two or more. The bene\ufb01 ts of \nuniversal screening for osteoporosis remain unproven, but some authorities rec-\nommend this for men and women over 70\u2014and earlier if risk factors are present.17\n  \n\u2022 DEXA is not needed pre-treatment for women over 75yrs if previous low-trauma \nfracture, or \u2265 2 present of rheumatoid arthritis, alcohol excess, or positive family \nhistory.\n  \n\u2022 Prior to giving long-term prednis olone (eg \ue0063 months at >5mg/d). Steroids cause \nosteoporosis by promoting osteoclast bone resorption, \ue001muscle mass, and \ue001Ca\n2+ \nabsorption from the gut.\n  \n\u2022 Men or women with osteopenia if low-trauma, non-vertebral fracture. \n  \n\u2022 Bone and bone-remodelling disorders (eg parathyroid disorders, myeloma, \nHIV, esp. if on protease inhibitors). \nDEXA bone densitometry: WHO osteoporosis criteria \nSteroid use of >5mg/d of prednisolone.\nHyperthyroidism, hyperparathyroidism, hypercalciuria.\nAlcohol and tobacco use \ue000.\nThin (BMI <18.5).\nTestosterone \ue001 (eg anti androgen ca prostate \ue057).\nEarly menopause.\nRenal or liver failure.\nErosive/in\ufb02 ammatory bone disease (eg myeloma or rheumatoid arthritis).\nDietary \ue001Ca\n2+/malab sorption; diabetes mellitus type 1.\nOsteoporosis risk factors: \u2018SHATTERED\u2019", "text_length": 2114, "metadata": {"source": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf (Part 691/905)", "type": "chunk", "chunk_index": 690, "total_chunks": 905, "uploaded_by": "admin@admin.com", "upload_date": "2025-12-11T17:59:53.357773", "document_uuid": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f", "filename": "8205Oxford Handbook of Clinical Medicine 10th 2017 Edition_SamanSarKo - Copy.pdf", "category": "medical_pdf", "section": "body", "year": 2017, "outdated": false, "document_id": "1c4b3c41-9a74-4d3d-ab11-d2a041c9641f"}, "created_at": "2025-12-11T17:59:53.358943", "status": "complete", "chunks_added": 2}